Sumatriptan in the treatment of migraine attacks

G. Nappi, G. Micieli

Research output: Contribution to journalArticlepeer-review


In this article, some of the problems encountered in the treatment of migraine attacks are evaluated on the basis of the experiences with the novel 5-HT1 agonist sumatriptan. The high specificity of the mechanism of action and the early onset of efficacy are considered to be important factors of this drug. The phenomenon of headache recurrence is discussed, together with the problem of the cost of sumatriptan.

Original languageEnglish
Pages (from-to)599-602
Number of pages4
JournalCurrent Therapeutic Research
Issue number5
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Sumatriptan in the treatment of migraine attacks'. Together they form a unique fingerprint.

Cite this